Estrogen Receptor Negative Recruiting Phase 2 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0036417 (Estrogen Receptor Negative)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02876107Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast CancerTreatment
NCT02593175Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBCTreatment